By Sola Ogundipe
A government panel of experts in India is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India.
India is currently administering AstraZeneca’s COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN.
According to Reuters, he review comes after Europe’s drug regulator, the European Medicines Agency, EMA, it found a possible link between AstraZeneca’s vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccine’s advantages still outweighed the risks.
India tahr is struggling to contain a record surge in COVID-19 cases in its second wave, reported 126,789 new cases on Thursday.
READ ALSO: AstraZeneca vaccine blood clot risk ‘very rare’ — EU regulator
A source said the…